A disappointing retail report and mixed results for Citigroup's second quarter weighed on markets Monday, though M&A news sparked life into pharma. More
-
-
Sponsored By:
-
Sponsored By:
RHHBY
Nestle’s is More Than Just Chocolate and Candy
Nestlé together with its subsidiaries, provides nutrition, health, and wellness products worldwide, and is an international dividend achiever. More
Medidata Solutions a Strong Buy in Cloud Computing
Medidata Solutions is a fast-growing cloud services provider to the health care industry that is poised for even better growth and is a buying opportunity More
Nestle: A Global Dividend Powerhouse
Nestle is a world wide brand name that produces products, earnings, and dividends at a remarkable rate every year. Nestle is a great portfolio buy. More
Obesity: The Next Investment Driver
The global market for weight-control products of all types is forecast to hit $53 billion in just five years, and several companies are primed to profit. More
Feel Safe Scooping Up Swiss Stocks
There's a lot to like about Switzerland as an investment haven. It's not a perfect environment, but a number of Swiss stocks look promising right now. More
Forecast: Top 15 Pharma Companies in 2018
Novartis will be No. 1, and just one U.S. firm will remain among the top 5, according to EvalutePharma's research. More
